Trailing-twelve-month (TTM) revenue is $1.39 Billion with a year-over-year growth of +28.89%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $310,880,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-05 |
| Q4 FY2025Period ended 2025-12-31 | $350,195,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-10 |
| Q1 FY2026Period ended 2026-03-31 | $358,005,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-05 |
| Q2 FY2026Period ended 2026-06-30 | $370,576,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-05 |
| TTM revenue | $1,389,656,000 |
Current P/S: $4,749,570,569 market capitalization ÷ $1,389,656,000 TTM revenue = 3.42x.
Market capitalization source: FMP quote. Quote observed 2026-09-22T20:00:02.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $370.58M.
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 14 comparable quarters.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-22T21:50:43.945Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|
| Asia Pacific | $96M | $127M |
| EMEA | $209M | N/A |
| Other Americas | $47M | $60M |
| UNITED STATES | $585M | $741M |
$1.39B
$1.39 Billion
+28.89%
vs. $1.08B a year ago (TTM)
+33.41%
3 Year compound annual growth rate
1 Year
+28.89%
3 Year
+33.41%
5 Year
N/A
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $1.23B | +$296.56M | +31.63% |
| 2024 | $937.46M | +$239.37M | +34.29% |
| 2023 | $698.10M | +$225.35M | +47.67% |
| 2022 | $472.75M | +$182.11M | +62.66% |
TTM Growth
+28.89%
3-Year CAGR
+33.41%
5-Year CAGR
N/A
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-22T21:50:43.945Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
